Andrew Hedin

Andrew Hedin

Direttore/Membro del Consiglio presso
Nido Biosciences, Inc.
41 anni
Health Technology
Finance
Consumer Services

Profilo

Andrew Hedin is a partner in Bessemer’s Cambridge office where he focuses on investments broadly across the healthcare ecosystem, including new biotech therapeutics as well as software and services sold to healthcare verticals.
Prior to joining Bessemer in 2015, Andrew worked at F-Prime Capital, Fidelity’s healthcare-focused venture capital fund where he invested in early-stage biotech and digital health technologies, as well as Leerink Partners as an advisor to the biopharma industry.
He earned an MBA with honors from The Wharton School, where he majored in health care management and finance, as well as a degree in biological basis of behavior from the University of Pennsylvania.

Posizioni attive di Andrew Hedin

SocietàPosizioneInizio
Investitore di Private Equity 01/07/2015
Direttore/Membro del Consiglio -

Precedenti posizioni note di Andrew Hedin

SocietàPosizioneFine
KYMERA THERAPEUTICS, INC. Direttore/Membro del Consiglio 16/06/2021
Analista di Private Equity 30/07/2013
TSCAN THERAPEUTICS, INC. Direttore/Membro del Consiglio -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Andrew Hedin

Formazione di Andrew Hedin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

34

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private8

Consumer Services

Finance

Finance

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Andrew Hedin